Supreme Court rules invalid Amgen's patent on cholesterol-lowering drug
The Supreme Court on Thursday ruled against the drug company Amgen, which had sued Sanofi for infringing Amgen’s patent on antibodies that lower LDL cholesterol, sometimes called “bad” cholesterol. Amgen’s patent is invalid, the court found, because it fails to provide enough information to enable o
Source: scotusblog.com